STAT+: KRAS, the ideal cancer drug target that became ‘undruggable,’ takes on a new glow
On Target is a recurring feature from STAT that dives deep into the most promising…
Category: On Target
Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is
On Target is a recurring feature from STAT that dives deep into the most promising…
In the search for therapies for solid tumors, companies are turning to a novel target: claudin-6
On Target is a recurring feature from STAT that dives deep into the most promising…
STAT+: Frustrated with nature’s biomarkers for cancer, biologists try making their own
On Target is a recurring feature from STAT that dives deep into the most promising…
STAT+: After a dry spell for cancer immunotherapy, a new target offers a beacon of hope
Oncologists may soon have a new immuno-oncology target in their arsenal. Experts expect the Food…